Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

St. Jude Medical (STJ) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 22,711,560
  • Shares Outstanding, K 285,590
  • Annual Sales, $ 5,541 M
  • Annual Income, $ 880 M
  • 36-Month Beta 1.24
  • Price/Sales 4.10
  • Price/Book 5.06

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.38 +1.66%
on 11/08/16
80.66 -1.21%
on 11/21/16
+0.72 (+0.91%)
since 11/07/16
3-Month
77.32 +3.05%
on 11/03/16
81.53 -2.27%
on 10/10/16
+0.50 (+0.63%)
since 09/07/16
52-Week
48.83 +63.18%
on 02/11/16
84.00 -5.14%
on 08/08/16
+18.06 (+29.31%)
since 12/07/15

Most Recent Stories

More News
US Market Report for Neuromodulation Devices 2017 - MedCore

DescriptionMarket growth will be propelled by wider acceptance of neuromodulation products, allowing them to be used on a larger proportion of potential patients. In addition, many neuromodulation patients...

St. Jude Medical's MOMENTUM 3 IDE Study Results Encourage

St. Jude Medical Inc. (STJ) recently announced positive results from its MOMENTUM 3 U.S. IDE Clinical Study, which compared the HeartMate 3 Left Ventricular Assist System (LVAS) to the HeartMate II LVAS....

St. Jude Medical HeartMate 3 LVAS Demonstrated Improved Clinical Outcomes for Patients Suffering from Advanced Heart Failure

--Results presented during late-breaking clinical trial session at the AHA Scientific Sessions

Research and Markets - Global Microelectronic Medical Implant Market Value of USD 57.12 Billion by 2025 - Trends, Technologies & Opportunities Report 2016-2025 - Vendors: Medtonic, Sorin Group, St. Jude Medical

Research and Markets has announced the addition of the "Microelectronic Medical Implant Market Analysis & Trends - Product, Technology - Forecast to 2025" report to their offering.

St Jude Medical Shares Up 47.2% Since SmarTrend's Buy Recommendation (STJ)

SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 9 months, St Jude Medical has returned 47.16% as of today's recent price of $79.73.

Medical Equipment Stocks on Investors' Radar -- St. Jude Medical, Edwards Lifesciences, Zimmer Biomet, and Stryker

This morning, Stock-Callers.com revisits the Medical Appliances and Equipment space, which is one of the biggest industries in healthcare, driven by innovation and new technologies. Equities to assess...

St. Jude Medical Gains CE Mark Approval for MRI Labeling of its Quadra Allure MP Cardiac Resynchronization Therapy Pacemaker

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval for magnetic resonance (MR) conditional labeling for the company's Quadra Allure...

St Jude Medical Has Returned 43.8% Since SmarTrend Recommendation (STJ)

SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 9 months, St Jude Medical has returned 43.76% as of today's recent price of $77.89.

United Kingdom Remote Patient Monitoring Market Outlook to 2022: Key Players Profiled are Biotronik SE & Co. KG, Medtronic plc, St. Jude Medical, Inc., GE Healthcare Limited - Research and Markets

Research and Markets has announced the addition of the "United Kingdom Remote Patient Monitoring Market Outlook to 2022" report to their offering.

Largest Observational Study to Date of the St. Jude Medical AMPLATZER Amulet Left Atrial Appendage Occluder Demonstrates High Implant Success and Strong Safety Profile

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today presented favorable results from the largest observational study to date of the company's AMPLATZER(TM) Amulet(TM)...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

St. Jude Medical, Inc. is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology...

See More

Support & Resistance

2nd Resistance Point 80.41
1st Resistance Point 80.04
Last Price 79.68
1st Support Level 78.95
2nd Support Level 78.23

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.